144 related articles for article (PubMed ID: 26775690)
1. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.
Chaisuparat R; Limpiwatana S; Kongpanitkul S; Yodsanga S; Jham BC
J Oral Pathol Med; 2016 Sep; 45(8):581-5. PubMed ID: 26775690
[TBL] [Abstract][Full Text] [Related]
2. Expression of Matrix Metalloproteinase-10 at Invasive Front of Squamous Cell Carcinoma and Verrucous Carcinoma in the Oral Cavity.
Kadeh H; Saravani S; Heydari F; Keikha M; Rigi V
Asian Pac J Cancer Prev; 2015; 16(15):6609-13. PubMed ID: 26434883
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
4. Pathologic significance of AKT, mTOR, and GSK3β proteins in oral squamous cell carcinoma-affected patients.
Matsuo FS; Andrade MF; Loyola AM; da Silva SJ; Silva MJB; Cardoso SV; de Faria PR
Virchows Arch; 2018 Jun; 472(6):983-997. PubMed ID: 29713826
[TBL] [Abstract][Full Text] [Related]
5. Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma.
Deng Z; Wang Y; Fang X; Yan F; Pan H; Gu L; Xie C; Li Y; Hu Y; Cao Y; Tang Z
Cancer Gene Ther; 2017 Jul; 24(7):282-288. PubMed ID: 28621315
[TBL] [Abstract][Full Text] [Related]
6. Stereology study of oral verrucous carcinoma.
Liu O; Zhang H; Wang Y; Quan H; Zhang J; Zhou J; Zuo J; Tang J; Fang X; Wang W; Zhao L; Tang Z
J BUON; 2012; 17(2):343-9. PubMed ID: 22740216
[TBL] [Abstract][Full Text] [Related]
7. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
8. Association of Macrophages With Angiogenesis in Oral Epithelial Dysplasia, Oral Verrucous Carcinoma, and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Chawla H; Urs AB; Augustine J
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):203-208. PubMed ID: 26657870
[TBL] [Abstract][Full Text] [Related]
9. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
10. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the association between miR‑181b, Bcl‑2 and LRIG1 in oral verrucous carcinoma.
Deng ZY; Wang YH; Quan HZ; Liu OS; Li YP; Li Y; Zhu W; Munnee K; Tang ZG
Mol Med Rep; 2016 Oct; 14(4):2991-6. PubMed ID: 27509922
[TBL] [Abstract][Full Text] [Related]
12. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia.
Sihavong P; Kitkumthorn N; Srimaneekarn N; Bumalee D; Lapthanasupkul P
Head Neck Pathol; 2021 Jun; 15(2):408-415. PubMed ID: 32720035
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.
de Vicente JC; Peña I; Rodrigo JP; Rodríguez-Santamarta T; Lequerica-Fernández P; Suárez-Fernández L; Allonca E; García-Pedrero JM
Head Neck; 2017 Sep; 39(9):1876-1887. PubMed ID: 28675642
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein S6 phosphorylation is associated with epithelial dysplasia and squamous cell carcinoma of the oral cavity.
Chaisuparat R; Rojanawatsirivej S; Yodsanga S
Pathol Oncol Res; 2013 Apr; 19(2):189-93. PubMed ID: 23015458
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity.
Klieb HB; Raphael SJ
Head Neck Pathol; 2007 Dec; 1(2):118-22. PubMed ID: 20614262
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
Yamada Y; Kohashi K; Fushimi F; Takahashi Y; Setsu N; Endo M; Yamamoto H; Tokunaga S; Iwamoto Y; Oda Y
Cancer; 2014 Mar; 120(6):864-76. PubMed ID: 24353015
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray analysis reveals the expression and prognostic significance of phosphorylated AktThr³⁰⁸ in oral squamous cell carcinoma.
Li Y; Wang J; Wang F; Wang H; Wang J; Zeng X; Liao G; Dan H; Chen Q
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Nov; 116(5):591-7. PubMed ID: 24018125
[TBL] [Abstract][Full Text] [Related]
20. MCM-2 expression differentiates potentially malignant verrucous lesions from oral carcinomas.
Niranjan KC; Sarathy NA; Alrani D
Ann Diagn Pathol; 2018 Jun; 34():72-76. PubMed ID: 29661732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
